Last $51.95 USD
Change Today 0.00 / 0.00%
Volume 0.0
SNY On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
Frankfurt
Frankfurt
NASDAQ GM
As of 8:04 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for sanofi-adr (SNY)

This company's management employs a level of debt in the capital structure that appears to be in-line with industry norms. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 79.41 days worth of sales outstanding. Last, Sanofi is among the most efficient in its industry at managing inventories, with only 211.41 days of its Cost of Goods Sold tied up in inventory.
View Balance Sheet In Euro
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
USD
Dec 31
2011
Restated
USD
Dec 31
2012
Restated
USD
Dec 31
2013
USD
4 Year
Trend
Assets    
Cash and Equivalents8,703.45,551.98,590.311,115.8
Short-Term Investments31.047.175.479.4
Trading Asset Securities1.3121.253.832.3
TOTAL CASH AND SHORT TERM INVESTMENTS8,735.75,720.18,719.511,227.6
Accounts Receivable8,759.910,826.410,106.19,196.1
Other Receivables2,442.12,887.72,823.02,723.4
TOTAL RECEIVABLES11,202.013,714.012,929.211,919.5
Inventory6,758.18,146.08,587.68,551.3
Prepaid Expenses250.4344.6347.3355.4
Other Current Assets9,508.4154.8246.4156.2
TOTAL CURRENT ASSETS36,454.628,079.730,830.032,209.9
Gross Property Plant and Equipment19,353.424,514.825,745.326,333.6
Accumulated Depreciation-8,374.9-10,042.9-11,504.9-12,626.3
NET PROPERTY PLANT AND EQUIPMENT10,978.514,472.014,240.413,707.3
Goodwill42,987.851,940.251,255.049,990.9
Long-Term Investments2,342.42,839.24,114.15,945.0
Loans Receivable, Long Term650.2771.4935.6910.1
Deferred Tax Assets, Long Term4,107.34,896.25,895.15,592.2
Deferred Charges, Long Term2,898.46,192.75,496.72,683.0
Other Intangibles13,901.225,630.921,686.418,042.2
Other Long-Term Assets464.4705.4720.2245.0
TOTAL ASSETS114,785.0135,527.7135,173.6129,325.6
    
LIABILITIES & EQUITY    
Accounts Payable3,769.44,285.14,294.54,042.7
Accrued Expenses1,899.52,634.62,570.02,475.7
Short-Term Borrowings1,357.01,319.3341.9632.7
Current Portion of Long-Term Debt/Capital Lease753.92,675.04,792.64,989.1
Current Portion of Capital Lease Obligations8.116.217.517.5
Current Income Taxes Payable1,056.81,427.01,258.71,320.7
Other Current Liabilities, Total6,993.75,946.35,453.65,329.7
TOTAL CURRENT LIABILITIES15,830.318,287.218,711.318,790.7
Long-Term Debt8,987.416,718.814,342.713,952.3
Capital Leases25.6107.787.567.3
Minority Interest257.1228.9180.4173.7
Pension & Other Post-Retirement Benefits5,712.15,164.17,056.95,418.6
Deferred Tax Liability Non-Current5,126.48,790.97,985.86,811.9
Other Non-Current Liabilities7,365.210,581.49,626.97,530.8
TOTAL LIABILITIES43,047.159,650.157,811.252,571.6
Common Stock3,529.83,610.63,571.53,566.2
Additional Paid in Capital67,539.071,941.271,210.271,421.5
Treasury Stock-499.5-1,256.0-278.7-328.5
Comprehensive Income and Other911.41,353.02,679.01,921.1
TOTAL COMMON EQUITY71,480.875,648.777,182.176,580.3
TOTAL EQUITY71,737.975,877.677,362.576,754.0
TOTAL LIABILITIES AND EQUITY114,785.0135,527.7135,173.6129,325.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNY:US $51.95 USD 0.00

SNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €100.65 EUR +0.36
Gilead Sciences Inc $90.34 USD 0.00
GlaxoSmithKline PLC 1,466 GBp -16.00
Merck & Co Inc $58.11 USD 0.00
Novo Nordisk A/S kr250.90 DKK -5.30
View Industry Companies
 

Industry Analysis

SNY

Industry Average

Valuation SNY Industry Range
Price/Earnings 26.5x
Price/Sales 3.0x
Price/Book 1.8x
Price/Cash Flow 15.1x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI-ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.